Abstract:Abstract Malignant tumor cells overexpress and release nanosized, lipid-enclosed vesicles referred to as exosomes into body fluids for the primary function of facilitating cell-to-cell communication and transferring vital proteins necessary for survival to other parts of the body, resulting in metastasis. It was found that an increased secretion of exosomes in the peripheral blood is correlated to lung cancer and melanoma metastasis. The hallmarks of exosomes are their highly curved membrane surface (d = ∼30-100 nm) and their enrichment in the anionic lipid phosphatidylserine (PS) in the outer leaflet of the membrane bilayer. These properties may provide unique strategies in designing peptides to selectively target exosomes as potential cancer biomarkers. Some current clinical methods that are being used to classify metastatic patients, such as the biopsy and assays measuring circulating tumor cells, are not reproducible and do not always indicate whether or not treatment is reducing metastasis. Furthermore, these methods involve invasive procedures. We aim to develop a novel, minimally invasive, peptide-based diagnostic tool to detect and measure exosome overexpression in cancer patients. The successful creation of this diagnostic tool for cancer metastasis will help in the proper prognosis and therapy for cancer patients. We rationally chose the effector domain of the intracellular membrane protein myristoylated alanine-rich C-kinase substrate (MARCKS) as our core molecule based on recent reports that this peptide differentially interacts with nanometer size synthetic lipid vesicles. It has also been shown that MARCKS inserts its five hydrophobic phenylalanine (Phe) residues into the membrane of highly curved synthetic lipid vesicles, and its binding affinity increases with increasing vesicle curvature, presumably corresponding to a larger number of defects on the membrane surface. We hypothesize that as vesicle curvature increases, the Phe residues will insert deeper into the membrane due to more lipid defects exposed on the membrane surface in highly curved vesicles. Five analogs of the MARCKS peptide were synthesized, substituting one Phe residue with a cysteine residue for all 5 Phe positions. The cysteine was then labeled with 1-oxyl-2,2,5,5-tetramethyl-▵3-pyrroline-3-methyl) methanethiosulfonate (MTSL), which will be used as a paramagnetic spin label for electron paramagnetic resonance spectroscopy (EPR). The depth parameter of insertion of the MTSL into the lipid vesicle membrane at each of the five cysteine positions will be quantified using EPR and will be reported herein. Citation Format: Sara K. Coulup, Leslie A. Morton, Hang Yin. MARCKS-ED peptide targets highly curved vesicles: Potential probe for exosome detection. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2233. doi:10.1158/1538-7445.AM2013-2233 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA

Matrix stiffness regulates the protein profile of extracellular vesicles of pancreatic cancer cell lines

Extracellular Vesicles Potentiate Medulloblastoma Metastasis in an EMMPRIN and MMP-2 Dependent Manner

Tethered exosomes containing MT1-MMP contribute to extracellular matrix degradation during breast cancer progression

Proteomic and functional profiling of platelet-derived extracellular vesicles released under physiological or tumor-associated conditions

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding

Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness

Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model

The release of tryptase from mast cells promote tumor cell metastasis via exosomes

An EpCAM/Trop2 mechanostat differentially regulates collective behaviour of human carcinoma cells

Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases

Cancer cell extravasation requires iplectin-mediated delivery of MT1-MMP at invadopodia

ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium

Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics

The Role of Extracellular Matrix Proteins in Breast Cancer

Small extracellular vesicles promote stiffness-mediated metastasis

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

Electroporation-derived melanoma extracellular particles activate fibroblasts

Abstract 2233: MARCKS-ED Peptide Targets Highly Curved Vesicles: Potential Probe for Exosome Detection.

Malignant effusions and immunogenic tumour-derived exosomes